Reversible splenial lesion syndrome in neuroleptic malignant syndrome. by Al-Edrus, Sharifah Aishah et al.
Reversible splenial lesion syndrome in neuroleptic malignant syndrome. 
ABSTRACT 
Background: Reversible focal lesions in the splenium of the corpus callosum (SCC) or 
reversible splenial lesion syndrome are rare and little is known about their pathophysiology. 
Case summary: The authors describe a case of a 65-year-old female who presented with 
fever, abnormal behaviour and mild hypernatremia. She was on neuropsychiatric treatment 
for bipolar disorder but denied any history of seizure. After an extensive workout to exclude 
infection, a clinical diagnosis of neuroleptic malignant syndrome (NMS) was made. Initial 
magnetic resonance imaging (MRI) of the brain showed a lesion in the SCC characterized by 
high-signal intensity on T2-weighted and FLAIR sequences with reduced signal intensity on 
T1-weighted sequence. Diffuse weighted imaging (DWI) showed restricted diffusion. There 
was no enhancement following Gadolinium administration. The follow-up MRI 8 weeks later 
showed complete resolution of the SCC lesion. Conclusion: While the pathophysiology of 
reversible SCC lesions is still unclear, this case highlights the need to consider NMS in the 
differential diagnosis of reversible splenial lesion of the corpus callosum.  
  
Keyword: Corpus callosum; Neuroleptic malignant syndrome; Reversible splenial.  
 
